Auricular Fibrillation
Conditions
Interventions
The case group:fluvastatin + benazepril
The control group:fluvastatin
Sponsors
the First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The diagnosis of AF was made based on electrocardiogram and dynamic electrocardiogram; no renal insufficiency and renal artery stenosis, or hyperkalemia as contraindications of angiotensin-converting enzyme inhibitor (ACEI) drugs; patients are informed consent and willing to take part in the clinical observation and follow up.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Congenital heart disease and rheumatic heart disease; LVEF < 40%; hyperthyroidism; severe valvular disease, such as severe mitral insufficiency and over moderate aortic valve insufficiency; chronic inflammatory diseases or connective tissue diseases, including chronic obstructive pulmonary disease and rheumatoid arthritis; experienced acute infection, hemorrhage in any tissue or organ, trauma and surgery within 3 months; major organ failure, such as lung, liver and kidney failure; allergic to ACEI and statins.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clincal Efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sinus rhythm conversion; | — |
Countries
China
Contacts
Public ContactLiang Zhaoguang
Department of Cardiology, the First Affiliated Hospital of Harbin Medical University
Outcome results
None listed